About
Laura Brass PhD, MBA is a Managing Director at the Novartis Venture Fund in Cambridge, MA, USA. Prior to NVF, Laura was a Managing Director at MPM Capital and, before that, a member of the founding management team and SVP BD for TriNetX. Laura has held various roles in business development and IP strategy, and was CEO of Aferon, an early-stage antiviral start-up. Laura holds a BA in Philosophy and BS in Biochemistry from the University of Missouri-Columbia, as well as a PhD in Molecular Genetics and Cell Biology and MBA, both from the University of Chicago.
Investments
- Anokion (Board Director)
- Immunitas Therapeutics (Board Director)
- Seawolf Therapeutics (Board Director)
- HYKU Biosciences (Board Director)
- Expansion Therapeutics (Observer)
- Tagworks Pharmaceuticals (Observer)
Successes
- Annexon (IPO)